Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5578
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease ; day:18 ; month:10 ; year:2022 ; pages:1-13
Molecular psychiatry ; (18.10.2022), 1-13
- Creator
-
Nowell, Joseph
Blunt, Eleanor
Edison, Paul
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41380-022-01792-4
- URN
-
urn:nbn:de:101:1-2023010321030585289681
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:31 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nowell, Joseph
- Blunt, Eleanor
- Edison, Paul
- SpringerLink (Online service)
Other Objects (12)
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer’s disease and Parkinson’s disease
Gray Matter Changes in Parkinson’s and Alzheimer’s Disease and Relation to Cognition
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Alzheimer, Parkinson und andere Alterskrankheiten
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer’s disease and Parkinson’s disease
Gray Matter Changes in Parkinson’s and Alzheimer’s Disease and Relation to Cognition
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Alzheimer, Parkinson und andere Alterskrankheiten
Measuring compounds in exhaled air to detect Alzheimer´s disease and Parkinson´s disease
Parkinson’s disease and Alzheimer’s disease: a Mendelian randomization study
Modeling the neuroimmune system in Alzheimer’s and Parkinson’s diseases
The aging immune system in Alzheimer’s and Parkinson’s diseases
Comparing Alzheimer’s and Parkinson’s diseases networks using graph communities structure
Facial emotion expressivity in patients with Parkinson’s and Alzheimer’s disease
Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer’s disease and Parkinson’s disease
Gray Matter Changes in Parkinson’s and Alzheimer’s Disease and Relation to Cognition
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer’s and Parkinson’s disease
The human olfactory system in two proteinopathies: Alzheimer’s and Parkinson’s diseases
Circulatory miR-223-3p Discriminates Between Parkinson’s and Alzheimer’s Patients
Alzheimer, Parkinson und andere Alterskrankheiten